← Back to Screener
Sana Biotechnology, Inc. Common Stock (SANA)
Price$2.68
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-45.60%
Price vs S&P 500 (4W)-23.64%
VGM Score37.68
Market Capitalization$745.82M
All Metrics
Book Value / Share (Quarterly)$0.44
P/TBV (Annual)10.66x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.50
Price vs S&P 500 (YTD)-42.31%
EPS (TTM)$-0.94
10-Day Avg Trading Volume4.11M
EPS Excl Extra (TTM)$-0.94
EPS (Annual)$-0.96
ROI (Annual)-151.77%
Cash / Share (Quarterly)$0.37
ROA (Last FY)-58.57%
EBITD / Share (TTM)$-0.90
ROE (5Y Avg)-91.92%
Cash Flow / Share (Annual)$-0.54
P/B Ratio6.25x
P/B Ratio (Quarterly)6.52x
Net Income / Employee (Annual)$-1,719,500
ROA (TTM)-60.97%
EPS Incl Extra (Annual)$-0.96
Current Ratio (Annual)1.89x
Quick Ratio (Quarterly)1.22x
3-Month Avg Trading Volume3.23M
52-Week Price Return5.10%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$0.22
52-Week High$6.55
EPS Excl Extra (Annual)$-0.96
CapEx CAGR (5Y)-47.66%
26-Week Price Return-37.67%
Quick Ratio (Annual)1.81x
13-Week Price Return-21.41%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.29x
Enterprise Value$662.02M
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.52
3-Month Return Std Dev68.73%
Net Income / Employee (TTM)$-1,704,100
ROE (Last FY)-151.77%
EPS Basic Excl Extra (Annual)$-0.96
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.94
ROI (TTM)-161.87%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$0.38
Price vs S&P 500 (52W)-19.27%
Year-to-Date Return-34.15%
5-Day Price Return-16.51%
EPS Normalized (Annual)$-0.96
ROA (5Y Avg)-45.24%
Month-to-Date Return-18.79%
Cash Flow / Share (TTM)$-1.33
EBITD / Share (Annual)$-0.94
ROI (5Y Avg)-91.92%
EPS Basic Excl Extra (TTM)$-0.94
P/TBV (Quarterly)12.94x
P/B Ratio (Annual)6.74x
Book Value / Share (Annual)$0.60
Price vs S&P 500 (13W)-29.66%
Beta2.24x
Revenue / Share (TTM)$0.00
ROE (TTM)-161.87%
52-Week Low$2.26
mGradeD
vgmGradeD
Show chart for
Earnings Surprise History
Q1 26-0.17est. -0.17
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
4.27
4.27
4.27
4.27
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SANASana Biotechnology, Inc. Common Stock | — | — | D | $2.68 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Sana Biotechnology develops engineered cell therapies to treat diseases across multiple therapeutic areas, including oncology, diabetes, B-cell-mediated autoimmune disorders, and central nervous system conditions. The company's pipeline includes several product candidates in development, addressing significant unmet medical needs in these high-value treatment markets.